Publikationen von Julia Sacher

Sacher, J.; Rabiner, E. A.; Clark, M.; Rusjan, P.; Soliman, A.; Boskovic, R.; Kish, S. J.; Wilson, A. A.; Houle, S.; Meyer, J. H.: Dynamic, adaptive changes in MAO-A binding after alterations in substrate availability: An in vivo [(11)C]-harmine positron emission tomography study. Journal of Cerebral Blood Flow and Metabolism 32 (3), S. 443 - 446 (2012)

Smith, G. S.; Kahn, A.; Sacher, J.; Rusjan, P.; van Eimeren, T.; Flint, A.; Wilson, A. A.: Serotonin transporter occupancy and the functional neuroanatomic effects of citalopram in geriatric depression. The American Journal of Geriatric Psychiatry 19 (12), S. 1016 - 1025 (2011)

Sacher, J.; Houle, S.; Parkes, J.; Rusjan, P.; Sagrati, S.; Wilson, A. A.; Meyer, J. H.: Monoamine oxidase A inhibitor occupancy during treatment of major depressive episodes with moclobemide or St. John's wort: An [(11)C]-harmine PET study. Journal of Psychiatry & Neuroscience 36 (6), S. 375 - 382 (2011)

Bacher, I.; Houle, S.; Xu, X.; Zawertailo, L.; Soliman, A.; Wilson, A. A.; Selby, P.; George, T. P.; Sacher, J.; Miler, L. et al.; Kish, S. J.; Rusjan, P.; Meyer, J. H.: Monoamine oxidase A binding in the prefrontal and anterior cingulate cortices during acute withdrawal from heavy cigarette smoking. Archives of General Psychiatry 68 (8), S. 817 - 826 (2011)

Sacher, J.; Wilson, A. A.; Rusjan, P. M.; Jacobs, L.; Bloomfield, P. M.; Houle, S.; Meyer, J. H.: Monoamine oxidase A (MAO-A)binding in prefrontal and anterior cingulate cortex in postpartum depression. Biological Psychiatry 69 (9), S. 157S - 157S (2011)

Soliman, A.; Bagby, R. M.; Wilson, A. A.; Miler, L.; Clark, M.; Rusjan, P.; Sacher, J.; Houle, S.; Meyer, J. H.: Relationship of monoamine oxidase A binding to adaptive and maladaptive personality traits. Psychological Medicine 41 (5), S. 1051 - 1060 (2011)

Sacher, J.; Wilson, A. A.; Houle, S.; Rusjan, P.; Hassan, S.; Bloomfield, P. M.; Stewart, D.; Meyer, J. H.: Elevated brain monoamine oxidase A binding in early postpartum period. Archives of General Psychiatry 67 (5), S. 468 - 474 (2010)

Schroeter, M. L.; Abdul-Khaliq, H.; Sacher, J.; Steiner, J.; Blasig, I. E.; Müller, K.: Mood disorders are glial disorders: Evidence from in vivo studies. Cardiovascular Psychiatry and Neurology 2010, 780645 (2010)

Kasper, S.; Sacher, J.; Klein, N.; Mossaheb, N.; Attarbaschi-Steiner, T.; Lanzenberger, R.; Spindelegger, C.; Asenbaum, S.; Holik, A.; Dudczak, R.: Differences in the dynamics of serotonin reuptake transporter occupancy may explain superior clinical efficacy of escitalopram versus citalopram. International Clinical Psychopharmacology 24 (3), S. 119 - 125 (2009)

Meyer, J. H.; Wilson, A. A.; Sagrati, S.; Miler, L.; Rusjan, P.; Bloomfield, P. M.; Clark, M.; Sacher, J.; Voineskos, A. N.; Houle, S.: Brain monoamine oxidase a binding in major depressive disorder: Relationship to selective serotonin reuptake inhibitor treatment, recovery and recurrence. Archives of General Psychiatry 66 (12), S. 1304 - 1312 (2009)

Sacher, J.; Mossaheb, N.; Spindelegger, C.; Klein, N.; Geiss-Granadia, T.; Sauermann, R.; Lackner, E.; Joukhadar, C.; Müller, M.; Kasper, S.: Effects of olanzapine and ziprasidone on glucose tolerance in healthy volunteers. Neuropsychopharmacology 33 (17), S. 1633 - 1641 (2008)

Attarbaschi, T.; Sacher, J.; Geiss-Granadia, T.; Klein, N.; Mossaheb, N.; Lanzenberger, R.; Asenbaum, S.; Dudczak, R.; Kasper, S.; Tauscher, J.: Striatal D(2) receptor occupancy in bipolar patients treated with olanzapine. Eur Neuropsychopharmacol 17 (2), S. 102 - 7 (2007)

Klein, N.; Sacher, J.; Geiss-Granadia, T.; Mossaheb, N.; Attarbaschi, T.; Lanzenberger, R.; Holik, A.; Asenbaum, S.; Dudczak, R.; Tauscher, J. et al.; Kasper, S.: Higher serotonin transporter occupancy after multiple dose administration of escitalopram compared to citalopram: an [123I]ADAM SPECT study. Psychopharmacology 191 (2), S. 333 - 9 (2007)

Lanzenberger, R.; Mitterhauser, M.; Spindelegger, C.; Wadsak, W.; Klein, N.; Mien, L.-K.; Holik, A.; Attarbaschi, T.; Mossaheb, N.; Sacher, J. et al.; Geiss-Granadia, T.; Kletter, K.; Kasper, S.; Tauscher, J.: Reduced serotonin-1A receptor binding in social anxiety disorder. Biol Psychiatry 61 (9), S. 1081 - 9 (2007)

Sacher, J.; Asenbaum, S.; Klein, N.; Geiss-Granadia, T.; Mossaheb, N.; Poetzi, C.; Attarbaschi, T.; Lanzenberger, R.; Spindelegger, C.; Rabas, A. et al.; Heinze, G.; Dudczak, R.; Kasper, S.; Tauscher, J.: Binding kinetics of 123I[ADAM] in healthy controls: a selective SERT radioligand. Int J Neuropsychopharmacol 10 (2), S. 211 - 8 (2007)

Klein, N.; Sacher, J.; Geiss-Granadia, T.; Attarbaschi, T.; Mossaheb, N.; Lanzenberger, R.; Poetzi, C.; Holik, A.; Spindelegger, C.; Asenbaum, S. et al.; Dudczak, R.; Tauscher, J.; Kasper, S.: In vivo imaging of serotonin transporter occupancy by means of SPECT and [123I]ADAM in healthy subjects administered different doses of escitalopram or citalopram. Psychopharmacology 188 (3), S. 263 - 72 (2006)

Sacher, J.; Weigl, L.; Werner, M.; Hohenegger, M.: Delineation of myotoxicity induced by 3-hydroxy-3-methylglutaryl CoA reductase inhibitors in human skeletal muscle cells. J Pharmacol Exp Ther. 31 (3), S. 1032 - 41 (2005)

Klein , N.; Sacher, J.; Wallner, H.; Tauscher, J.; Kasper, S.: Therapy of treatment resistant depression: Focus on the management of TRD with atypical antipsychotics. CNS Spectrums 9 (11), S. 823 - 832 (2004)

Werner, M.; Sacher, J.; Hohenegger, M.: Mutual amplification of apoptosis by statin-induced mitochondrial stress and doxorubicin toxicity in human rhabdomyosarcoma cells. Br J Pharmacol. 143 (6), S. :715 - 24 (2004)

Sacher, J.: Die Rolle von hormonellen Übergangsphasen für Geschlechtsunterschiede in der psychischen Gesundheit. In: Genderperspektiven in der Medizin (GPmed): Abstractband zur Tagungsreihe an der Universität Leipzig, S. 64 - 65 (Hg. Stengler, K.). Pöge, Leipzig (2017)